Madison Scientific

Coming – July 6

Family Office Roundtable: Evaluating Medical Device Innovation

Date and Time

July 6

–

12:00 PM ET / 9:00 AM PT

Details will be provided upon RSVP approval

About this Event

Medical device innovation has long been an area of interest for family offices seeking to support companies that combine breakthrough technology with the potential to improve patient outcomes. But identifying the businesses with the greatest long-term potential requires more than understanding the science. It requires evaluating management, regulatory pathways, commercialization strategies, reimbursement dynamics, and the ability to execute.

Join FORCE Family Office for a candid online roundtable discussion featuring several experienced family office leaders as they share their perspectives on the medical device sector. The conversation will explore what attracts sophisticated private capital to the space, the characteristics that distinguish exceptional companies, and the lessons learned from years of evaluating healthcare innovation.

Topics will include:
  • Why medical devices continue to be an attractive sector for family offices
  • The qualities that define exceptional management teams
  • Key diligence considerations beyond the technology itself
  • Regulatory, reimbursement, and commercialization challenges
  • The importance of strategic partnerships and clinical validation
  • Current trends shaping the future of medical device innovation

The discussion will also feature Madison Scientific (MadSci), a medical technology company developing innovative solutions for hydrocephalus treatment. Notably, the company is backed by a family office, providing a unique perspective on the relationship between entrepreneurs and long-term private capital and how aligned partnerships can help advance transformative healthcare technologies.

Register today to reserve your space for this important event.

Sign Up Today

SHARE THIS EVENT

This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts and referenced statistics, contained in this presentation, including statements regarding future company strategy, operations, financial position, revenues, projected costs, plans and objectives of management, will be forward-looking statements.

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.